A new drug proven to lower the risk of hearing loss in children with cancer by up to 42% awaiting approval in the UK.
Hearing research
The first medication to prevent hearing loss, caused by commonly used antibiotics, has been developed by biotechnology company, Oricula Therapeutics.
RNID is delighted to join forces with the University College London to run the 2023 Hearing Therapeutics Summit this Septem
RNID funded research from The University of Manchester shows that hearing loss is unlikely to be a common symptom of Covid-19.
Our Innovation Seed Fund provides small grants to researchers to enable them to investigate new ideas about the causes, treatment and diagnosis of hearing loss, tinnitus, and other hearing-related conditions.
RNID, and especially those of us in the Research team, are extremely saddened to hear of the death of Dr Christian Füllgrabe.
Cameron has Norrie Disease, a condition that means he was born blind. Now, at 10 years old, he's almost entirely lost his hearing, too. Fearing a life of silent darkness for her child, his mother Carla tells their story.
A new genetic test that can help protect newborn babies from hearing loss has been approved for use in NHS hospitals.
There is a link between hearing loss and dementia – as hearing loss increases in severity, so does the risk of developing dementia.
This International Women's Day, we're celebrating six inspirational women working in hearing research, who have changed history for our communities.